Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to SBRT in Oligometastatic Prostate Cancer
NCT04624828Active, not recruiting
- Sponsor
- Humanitas Research Hospital
- Start
- Oct 2020
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in prostate cancer (PCa), sponsored by Humanitas Research Hospital. Primary endpoint: Immune evaluation. Started Oct 2020; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04624828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04624828.